NCT03712475View on ClinicalTrials.gov

Pharmacokinetics of Two Formulation of Pregabalin

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

September 16, 2018

Study Completion Date

December 3, 2018

Conditions
Diabetic Peripheral NeuropathyFibromyalgiaPartial Seizure Disorder
Interventions
DRUG

Pregabalin

pharmacokinetic study under fasting conditions

Trial Locations (1)

Unknown

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
collaborator

Taichung Veterans General Hospital

OTHER

lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT03712475 - Pharmacokinetics of Two Formulation of Pregabalin | Biotech Hunter | Biotech Hunter